首页 | 本学科首页   官方微博 | 高级检索  
     

理中汤加减治疗慢性心力衰竭及对患者血清BNP、IL-10及NOS水平的影响研究
引用本文:黄光明. 理中汤加减治疗慢性心力衰竭及对患者血清BNP、IL-10及NOS水平的影响研究[J]. 陕西中医, 2021, 0(2): 159-162. DOI: DOI:10.3969/j.issn.1000- 7369.2020.02.006
作者姓名:黄光明
作者单位:(芜湖市中医院心内科,安徽 芜湖 241000)
基金项目:安徽省重点研究与开发计划项目(201904a07020109)。
摘    要:目的:观察理中汤加减对慢性心力衰竭(CHF)患者临床症状改善、血清B型钠尿肽(BNP)、白细胞介素-10(IL-10)、一氧化氮合酶(NOS)水平的影响.方法:选取110例CHF患者随机分为观察组56例与对照组54例.对照组入院后给予常规抗心衰西药治疗,观察组在其基础上给予理中汤加减.比较两组短期(1个月内)临床疗效,...

关 键 词:慢性心力衰竭  理中汤  B型钠尿肽  白细胞介素-10  一氧化氮合酶

Modified Lizhong decoction on clinical symptoms and levels of serum BNP,IL-10 and NOS in patients with chronic heart failure
HUANG Guangming. Modified Lizhong decoction on clinical symptoms and levels of serum BNP,IL-10 and NOS in patients with chronic heart failure[J]. Shaanxi Journal of Traditional Chinese Medicine, 2021, 0(2): 159-162. DOI: DOI:10.3969/j.issn.1000- 7369.2020.02.006
Authors:HUANG Guangming
Affiliation:(Department of Cardiology,Wuhu Hospital of Traditional Chinese Medicine,Wuhu 241000,China)
Abstract:Objective:To observe the effects of modified Lizhong decoction on improvement of clinical symptoms and levels of serum B-type natriuretic peptide(BNP),interleukin-10(IL-10)and nitric oxide synthase(NOS)in patients with chronic heart failure(CHF).Methods:Totally 110 patients with CHF were selected and randomly divided into observation group(n=56)and control group(n=54).Control group was treated with conventional western medicine for anti-heart failure therapy after admission,and observation group was given modified Lizhong decoction on this basis.The clinical efficacy in short term(within 1 month)was compared between the two groups,and the improvement of clinical symptoms(TCM syndromes scores),as well as cardiac function biochemical indicators[BNP,hypersensitive troponin T(hs-TnT),N-terminal pro-brain natriuretic peptide(NT-proBNP)],inflammatory cytokines[tumor necrosis factor-α(TNF-α),IL-10,nuclear factor kappa beta(NF-κB)]and vascular endothelial cell indexes NO,NOS and adverse reactions were recorded before treatment after 3 months of treatment.Results:Within 1 month of treatment,the effective rate in observation group was significantly higher than that in control group(85.71%vs 68.52%).After 3 months of treatment,the scores of TCM syndromes and levels of BNP,hs-TnT,NT-proBNP,TNF-α,NF-κB,NO and NOS in the two groups showed decreasing trends compared with those before treatment(all P<0.05),and the changes were greater in observation group(all P<0.05).During treatment,the occurrence of adverse reactions in observation group were better than those in control group.Conclusion:Modified Lizhong decoction for patients with CHF can help improve the clinical symptoms and enhance the clinical efficacy.And its role mechanism may be related to reducing the levels of inflammatory factors and improving cardiac function and vascular endothelial cell function,and it is beneficial to the outcomes of the disease.
Keywords:Chronic heart failure  Lizhong decoction  B-type natriuretic peptide  Interleukin-10  Nitric oxide synthase
本文献已被 维普 等数据库收录!
点击此处可从《陕西中医》浏览原始摘要信息
点击此处可从《陕西中医》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号